Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHOTREXATE Cause Bladder cancer recurrent? 16 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Bladder cancer recurrent have been filed in association with METHOTREXATE (Methotrexate). This represents 0.0% of all adverse event reports for METHOTREXATE.

16
Reports of Bladder cancer recurrent with METHOTREXATE
0.0%
of all METHOTREXATE reports
2
Deaths
14
Hospitalizations

How Dangerous Is Bladder cancer recurrent From METHOTREXATE?

Of the 16 reports, 2 (12.5%) resulted in death, 14 (87.5%) required hospitalization.

Is Bladder cancer recurrent Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHOTREXATE. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does METHOTREXATE Cause?

Drug ineffective (70,142) Rheumatoid arthritis (29,254) Off label use (24,020) Pain (23,773) Drug intolerance (22,555) Arthralgia (21,831) Fatigue (19,885) Nausea (18,715) Joint swelling (17,657) Drug hypersensitivity (16,677)

What Other Drugs Cause Bladder cancer recurrent?

BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (231) PIOGLITAZONE (130) RANITIDINE (66) BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (28) MITOMYCIN (20) PEMBROLIZUMAB (20) ADALIMUMAB (19) GEMCITABINE\GEMCITABINE (19) GEMCITABINE (15) INTERFERON ALFA-2B (14)

Which METHOTREXATE Alternatives Have Lower Bladder cancer recurrent Risk?

METHOTREXATE vs METHOXSALEN METHOTREXATE vs METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA METHOTREXATE vs METHYL ALCOHOL METHOTREXATE vs METHYLCOBALAMIN METHOTREXATE vs METHYLDOPA

Related Pages

METHOTREXATE Full Profile All Bladder cancer recurrent Reports All Drugs Causing Bladder cancer recurrent METHOTREXATE Demographics